EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Cell Death Differ. 2020 May;27(5):1554-1568. doi: 10.1038/s41418-019-0435-1. Epub 2019 Oct 23.
Cell Death Differ. 2020.
PMID: 31645677
Free PMC article.
Like many infectious agents, EBV has evolved strategies to block host cell death, including through expression of viral homologues of cellular BCL-2 pro-survival proteins (vBCL-2s), such as BHRF1. ...BHRF1 interacts with the cellular pro-apoptot …
Like many infectious agents, EBV has evolved strategies to block host cell death, including through expression of viral homologues of …